Alkaptonuria (Q39990): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A alcaptonúria é caracterizada pelo acúmulo de ácido homogentísico (HGA) e seu produto oxidado ácido benzoquinona acético (BQA), levando ao escurecimento da urina quando deixada exposta ao ar, coloração cinza-azulada da esclera do olho e da hélice da orelha (ocronose), e doença articular incapacitante que envolve as articulações axiais e periféricas (artropatia ocronótica). | |||||||||||||||
| description / en | description / en | ||||||||||||||
Alkaptonuria is characterised by the accumulation of homogentisic acid (HGA) and its oxidised product benzoquinone acetic acid (BQA), leading to a darkening of the urine when it is left exposed to air, grey-blue colouration of the eye sclerae and the ear helix (ochronosis), and a disabling joint disease involving both the axial and peripheral joints (ochronotic arthropathy). | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1761652827 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:5C50.10 | |||||||||||||||
| Property / CURIE: CID11:5C50.10 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-5C50.10 | |||||||||||||||
| Property / Canary Token: dki-india-5C50.10 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: E70.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 05:37, 13 August 2026
Alkaptonuria is characterised by the accumulation of homogentisic acid (HGA) and its oxidised product benzoquinone acetic acid (BQA), leading to a darkening of the urine when it is left exposed to air, grey-blue colouration of the eye sclerae and the ear helix (ochronosis), and a disabling joint disease involving both the axial and peripheral joints (ochronotic arthropathy).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 5C50.10 |
||
| English | Alkaptonuria |
Alkaptonuria is characterised by the accumulation of homogentisic acid (HGA) and its oxidised product benzoquinone acetic acid (BQA), leading to a darkening of the urine when it is left exposed to air, grey-blue colouration of the eye sclerae and the ear helix (ochronosis), and a disabling joint disease involving both the axial and peripheral joints (ochronotic arthropathy). |
Statements
CID11:5C50.10
0 references
dki-india-5C50.10
0 references
Concluído
0 references
13 August 2026
0 references
